Evidence map›Paper›PMID 25023697›Full record

Observational studyMalaria journal2014

Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.

Lauren M Cohee, Linda Kalilani-Phiri, Sarah Boudova, Sudhaunshu Joshi, Rabia Mukadam, Karl B Seydel, Patricia Mawindo, Phillip Thesing, Steve Kamiza, Kingsley Makwakwa and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Malaria journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Trial
  9. Trial
  10. Trial
  11. Article
  12. Current update on malaria in pregnancy: a systematic review.Tropical diseases, travel medicine and vaccines · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Lauren M CoheeCenter for Vaccine Development, School of Medicine, University of Maryland, Baltimore, Maryland, USA. lcohee@medicine.umaryland.edu.
Linda Kalilani-Phiri
Sarah Boudova
Sudhaunshu Joshi
Rabia Mukadam
Karl B Seydel
Patricia Mawindo
Phillip Thesing
Steve Kamiza
Kingsley Makwakwa
Atis Muehlenbachs
Terrie E Taylor
Miriam K Laufer
University of Malawi · MWUniversity of Maryland, Baltimore · USBlantyre Institute for Community Ophthalmology · MWMichigan State University · USUniversity of Washington · US

Funding

FELLOWSHIP TRAINING PROGRAM IN VACCINOLOGYT32AI007524 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Marcelo B. Sztein · 1997 to 2026
$6.4M
IMMUNITY AND INFECTIONT32AI007540 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KAPER, JAMES B · 1998 to 2018
$2.2M
NIAID NIH HHS T32 AI007524NIAID NIH HHS T32 AI007540
6 · The paper itself

Abstract

backgroundMalaria during pregnancy results in adverse outcomes for mothers and infants. Intermittent preventive treatment (IPT) with sulphadoxine-pyrimethamine (SP) is the primary intervention aimed at reducing malaria infection during pregnancy. Although submicroscopic infection is common during pregnancy and at delivery, its impact throughout pregnancy on the development of placental malaria and adverse pregnancy outcomes has not been clearly established.

methodsQuantitative PCR was used to detect submicroscopic infections in pregnant women enrolled in an observational study in Blantyre, Malawi to determine their effect on maternal, foetal and placental outcomes. The ability of SP to treat and prevent submicroscopic infections was also assessed.

results2,681 samples from 448 women were analysed and 95 submicroscopic infections were detected in 68 women, a rate of 0.6 episodes per person-year of follow-up. Submicroscopic infections were most often detected at enrolment. The majority of women with submicroscopic infections did not have a microscopically detectable infection detected during pregnancy. Submicroscopic infection was associated with placental malaria even after controlling for microscopically detectable infection and was associated with decreased maternal haemoglobin at the time of detection. However, submicroscopic infection was not associated with adverse maternal or foetal outcomes at delivery. One-third of women with evidence of placental malaria did not have documented peripheral infection during pregnancy. SP was moderately effective in treating submicroscopic infections, but did not prevent the development of new submicroscopic infections in the month after administration.

conclusionsSubmicroscopic malaria infection is common and occurs early in pregnancy. SP-IPT can clear some submicroscopic infections but does not prevent new infections after administration. To effectively control pregnancy-associated malaria, new interventions are required to target women prior to their first antenatal care visit and to effectively treat and prevent all malaria infections.

Indexed as

AdultAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsAsymptomatic DiseasesDNA, ProtozoanDrug Administration ScheduleDrug CombinationsDrug ResistanceErythrocytesEthanolaminesFalse Negative ReactionsFemaleFetal DiseasesFluorenesFollow-Up StudiesAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsDNA, ProtozoanDrug CombinationsEthanolaminesfanasil, pyrimethamine drug combinationFluorenesHemeproteinshemozoinPyrimethamineQuinineSulfadoxine

Identifiers

PMID25023697
PMCPMC4110536
OpenAlexW2103631590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.